Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Itaú Corpbanca $1 billion rights offering
The offering included rights to subscribe for new shares and ADSs
Privia Health $174 million secondary offering
We advised Privia on its SEC-registered offering of stock
Warner Music Group $540 million notes offering
The high-yield senior notes are due 2029
Arrival $353.6 million follow-on and $320 million convertible notes offerings
The shares are listed on Nasdaq and the 3.5% green convertible senior notes are due 2026
Affirm Holdings $1.725 billion convertible senior notes offering
The 0% convertible notes are due 2026
Alignment Healthcare $193 million SEC-registered secondary offering
The shares are listed on the Nasdaq Global Select Market
Aptiv $1.5 billion senior notes offering
We advised Aptiv on its investment-grade debt offering
Banco Santander renovation of $25 billion U.S. commercial paper program
We advised Banco Santander on its program renovation
Crescera Capital Acquisition $201 million IPO
We advised Crescera Capital Acquisition, a SPAC, on its IPO and Nasdaq listing
JBS $1 billion senior notes offering
The 2.5% notes are due 2027